KIF20A expression is aberrant in various cancers, such as cervical squamous cell carcinoma (Zhang et al., 2016b), pancreatic cancer (Stangel et al., 2015) and glioma (Saito et al., 2017). This evidence concerns the gene KIF20A and central nervous system cancer.